C. Tausch

Breast cancer

Breast cancer

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

Aromatase, aromatase inhibitors, and breast cancer

Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Late Recurrences in Early Breast Cancer: For Whom and How Long Is Endocrine Therapy Beneficial?

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore

Breast Cancer Treatment

Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women

Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women

Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a

Extended adjuvant treatment with anastrozole: Results from the Austrian Breast and Colorectal Cancer Study Group Trial 6a (ABCSG-6a)